DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B

被引:22
|
作者
Chen, Yanmeng [1 ]
Shen, Bocun [1 ]
Zheng, Xiaochuan [1 ]
Long, Quanxin [1 ]
Xia, Jie [1 ]
Huang, Yao [1 ]
Cai, Xuefei [1 ]
Wang, Deqiang [1 ]
Chen, Juan [1 ]
Tang, Ni [1 ]
Huang, Ailong [1 ]
Hu, Yuan [1 ]
机构
[1] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Dept Infect Dis, Minist Educ,Inst Viral Hepatitis,Affiliated Hosp, 1 Yi Xue Yuan Rd, Chongqing 400016, Peoples R China
关键词
Hepatitis B virus; APOBEC3B; DHX9; interaction; attenuate; HEPATITIS-B-VIRUS; REPLICATION; RNA; MECHANISMS; INFECTION; MUTATION;
D O I
10.1080/22221751.2020.1725398
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B virus (HBV) is a partially double-stranded DNA virus that replicates by reverse transcription. We previously demonstrated that the host restriction factor-APOBEC3B (A3B) inhibited HBV replication which was dependent on its deaminase activity during reverse transcription. However, the host factors involved in the process of regulating the anti-HBV function of A3B are less known. In this research, to obtain a comprehensive understanding of the interaction networks of A3B, we conducted coimmunoprecipitation and mass spectrometry to identify A3B-interacting proteins in the presence of HBV. By this approach, we determined that DExD/H-box helicase 9 (DHX9) suppressed the anti-HBV effect of A3B, and this suppression was dependent on their interaction. Although DHX9 did not affect the deamination activity of A3B in vitro assay or the viral DNA editing of A3B in HepG2-NTCP cells that support HBV infection, it inhibited the binding of A3B with pgRNA. These data suggest that DHX9 can interact with A3B and attenuate the anti-HBV efficacy of A3B.
引用
收藏
页码:366 / 377
页数:12
相关论文
共 50 条
  • [21] APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription
    Chen, Yanmeng
    Hu, Jie
    Cai, Xuefei
    Huang, Yao
    Zhou, Xing
    Tu, Zeng
    Hu, Jieli
    Tavis, John E.
    Tang, Ni
    Huang, Ailong
    Hu, Yuan
    ANTIVIRAL RESEARCH, 2018, 149 : 16 - 25
  • [22] Apobec3B的真核表达及其抗HBV效应
    孙士敏
    范红梅
    别彩群
    河北医学, 2011, 17 (02) : 143 - 146
  • [23] Evidence for APOBEC3B mutagenesis in multiple human cancers
    Michael B Burns
    Nuri A Temiz
    Reuben S Harris
    Nature Genetics, 2013, 45 : 977 - 983
  • [24] Role and molecular mechanism of APOBEC3B in the development and of cancer
    Su, Nana
    Zhou, Erle
    Cui, Min
    Li, Hong
    Wu, Shuhua
    Zhang, Qian
    Cao, Zhang
    HELIYON, 2024, 10 (02)
  • [25] APOBEC3B, a molecular driver of mutagenesis in human cancers
    Jun Zou
    Chen Wang
    Xiangyi Ma
    Edward Wang
    Guang Peng
    Cell & Bioscience, 7
  • [26] APOBEC3B is an enzymatic source of mutation in breast cancer
    Michael B. Burns
    Lela Lackey
    Michael A. Carpenter
    Anurag Rathore
    Allison M. Land
    Brandon Leonard
    Eric W. Refsland
    Delshanee Kotandeniya
    Natalia Tretyakova
    Jason B. Nikas
    Douglas Yee
    Nuri A. Temiz
    Duncan E. Donohue
    Rebecca M. McDougle
    William L. Brown
    Emily K. Law
    Reuben S. Harris
    Nature, 2013, 494 : 366 - 370
  • [27] Computational quest of full-length apobec3B
    Demir, Ozlem
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [28] APOBEC3B is an enzymatic source of mutation in breast cancer
    Burns, Michael B.
    Lackey, Lela
    Carpenter, Michael A.
    Rathore, Anurag
    Land, Allison M.
    Leonard, Brandon
    Refsland, Eric W.
    Kotandeniya, Delshanee
    Tretyakova, Natalia
    Nikas, Jason B.
    Yee, Douglas
    Temiz, Nuri I. A.
    Donohue, Duncan E.
    McDougle, Rebecca M.
    Brown, William L.
    Law, Emily K.
    Harris, Reuben S.
    NATURE, 2013, 494 (7437) : 366 - 370
  • [29] The APOBEC3B cytidine deaminase is an adenovirus restriction factor
    Lejeune, Noemie
    Mathieu, Sarah A.
    Decloux, Alexandra F.
    Poulain, Florian
    Blockx, Zoe F.
    Raymond, Kyle
    Willemart, Kevin F.
    Vartanian, Jean-Pierre
    Suspene, Rodolphe F.
    Gillet, Nicolas
    PLOS PATHOGENS, 2023, 19 (02)
  • [30] APOBEC3B, a molecular driver of mutagenesis in human cancers
    Zou, Jun
    Wang, Chen
    Ma, Xiangyi
    Wang, Edward
    Peng, Guang
    CELL AND BIOSCIENCE, 2017, 7